NCT00194753 - Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Breast Neoplasm

Interventions

DRUG

Paclitaxel

80 mg/m2 IV for 12 weeks following completion of doxorubicin and cyclophosphamide

DRUG

Doxorubicin

24 mg/m2 IV weekly x 12

DRUG

Cyclophosphamide

60 mg/m2 PO daily for 12 weeks

DRUG

G-CSF

5 mcg per kg subcutaneously days 2 - 7 during doxorubicin and cyclophosphamide for 12 weeks

Trial Locations (1)

University of Washington/Seattle Cancer Care Alliance, Seattle